[artículo] 
inJournal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 349-357

Título :	Pharmacokinetic and pharmacodynamic evaluation of the inhibition of alprazolam by citalopram and fluoxetine
Tipo de documento:	texto impreso
Autores:	Judith Hall, Autor ; Claudio A. Naranjo, Autor ; Beth A. Sproule, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 349-357
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Alprazolam, Ansiolíticos, Antidepresivos, Interacciones medicamentosas, Fluoxetina.
Resumen:	The selective serotonin reuptake inhibitor antidepressant fluoxetine inhibits alprazolam metabolism in vivo by inhibition of the cytochrome P 450 3A4 enzyme. Citalopram is a selective serotonin reuptake inhibitor antidepressant that has not yet been fully evaluated with respect to its potential for cytochrome P 450 3A4-mediated drug interactions in vivo.
Link:	./index.php?lvl=notice_display&id=31009

[artículo] Pharmacokinetic and pharmacodynamic evaluation of the inhibition of alprazolam by citalopram and fluoxetine [texto impreso] / Judith Hall, Autor ; Claudio A. Naranjo, Autor ; Beth A. Sproule, Autor . - 2023 . - pp. 349-357.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 349-357

Palabras clave:	Alprazolam, Ansiolíticos, Antidepresivos, Interacciones medicamentosas, Fluoxetina.
Resumen:	The selective serotonin reuptake inhibitor antidepressant fluoxetine inhibits alprazolam metabolism in vivo by inhibition of the cytochrome P 450 3A4 enzyme. Citalopram is a selective serotonin reuptake inhibitor antidepressant that has not yet been fully evaluated with respect to its potential for cytochrome P 450 3A4-mediated drug interactions in vivo.
Link:	./index.php?lvl=notice_display&id=31009